tirzepatide death Semaglutide and both cut risk of hospitalization for heart failure or by over 40% in patients with cardiometabolic #HFpEF. https://t.co/Dc388bFirG Wegovy cuts risk of heart

Research suggests that GLP-1 users prefer sugar to artificial sweeteners, as they are increasingly attracted to more 'natural' food that feels 'worthwhile' with their smaller appetites

President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD.

Novo Nordisk announced that its rebranded and reformulated oral GLP-1 medication, formerly known as Rybelsus, is now available in the U.S

Semaglutide side effects typically emerge within the first week of treatment, peak around weeks two through four, and often improve substantially by week six

Learn about their efficacy in controlling blood sugar and promoting wellness.

Each sleek, pre-filled multi-dose device delivers high-purity Semaglutide directly to receptors with advanced efficiency